Qtron Investments’s AngioDynamics ANGO Stock Holding History

Qtron Investments’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-11,848	Closed	-$271K	–	239
2019 Q1	$271K	Hold	11,848	–	–	0.25%	139
2018 Q4	$239K	Buy	+11,848	New	+$245K	0.18%	139

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TCM

Tributary Capital Management Omaha, Nebraska $1.22B AUM 44.12% 1-Year Est. Return

Qtron Investments's ANGO Position: Q2 2019 in Review

Qtron Investments sold out of AngioDynamics (ANGO) in Q2 2019, closing a stake of 11,848 shares — an estimated $271K sold.

Qtron Investments first reported a position in ANGO in Q4 2018 and held it in 2 quarters. The position peaked at $271K in Q1 2019. 167 funds tracked by Wall St. Rank hold ANGO as of Q2 2019.

Qtron Investments reported no remaining AngioDynamics position as of Q2 2019 after selling out during the quarter.
Qtron Investments sold 11,848 AngioDynamics shares in Q2 2019, an estimated $271K.
Qtron Investments first reported a position in AngioDynamics in Q4 2018 and held it in 2 quarters.
Qtron Investments's AngioDynamics position peaked at $271K in Q1 2019.
167 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2019.

Based on Qtron Investments's 13F filing for Q2 2019, filed 13 Aug 2019.